In healthcare, the holy graille seems to be longevity. We look at whether a treatment increases lifespan and use that as a barometer for it's value.
But should that be the yardstick we use? Or would we be better off with a more subjective measure of improving quality of life, even if that means sacrificing some of the quantity.
Today, 2 Docs Talk about this question propose some things to consider as you consider your approach to aging and healthcare.
Colonoscopy study in the Annals of Internal Medicine
Research on lifespan in Nature
The Austad/Olshansky Wager